A new life-long hemorrhagic disorder due to excess plasminogen activator.
A life-long bleeding disorder is described, characterized by hemorrhage occurring after surgery, injury, or dental extraction, and finally by spontaneous intracerebral bleeding. No abnormality of platelet function or plasma coagulation was demonstrable, but grossly enhanced overall fibrinolytic activity was present. The patient had, additionally, a hyperlipidemia with gross arterial atheroma and a family history of myocardial infarction but not of any hemorrhagic disorder. Laboratory studies led to the conclusion that the enhanced fibrinolysis was due to consistently greatly raised levels of a plasma plasminogen activator physically and immunologically related to that in human tissues and blood vessel endothelium. No deficiency of any known inhibitor of fibrinolysis was detected. Free plasmin was not detectable in functional assays but continuous intravascular plasmin generation clearly occurred as evidenced by presence of plasmin-alpha 2-antiplasmin complexes and of fibrin/fibrinogen-related antigens. Excessive production of plasminogen activator appeared to have occurred throughout life and to be independent of the hyperlipidemia. The pathologically increased fibrinolytic activity may have accounted for the complete absence of detectable thrombotic vascular occlusion at autopsy despite extensive arterial disease with severe narrowing of coronary and cerebral arteries.
D001780:Blood Coagulation Tests; D002543:Cerebral Hemorrhage / Q000150:complications; D005342:Fibrinolysis; D006406:Hematoma / Q000209:etiology; D006474:Hemorrhagic Disorders / Q000150:complications / Q000209:etiology*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000235:genetics; D007122:Immunoelectrophoresis; D008297:Male; D008875:Middle Aged; D010960:Plasminogen Activators / Q000096:biosynthesis*; D000979:alpha-2-Antiplasmin / Q000276:immunology
D000979:alpha-2-Antiplasmin; D010960:Plasminogen Activators